POSC94 Cost-Effectiveness of Risdiplam Versus Nusinersen for Treating Patients with Spinal Muscular Atrophy Type 1 in China
| Autor: | Hu, J, Sutherland, CS, Aponte Ribero, V, Zhu, L, Hou, X, Xia, Y, Tang, M, Jin, C, Kang, Q |
|---|---|
| Zdroj: | In Value in Health January 2022 25(1) Supplement:S105-S105 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect